Metformin, sold under the brand name Glucophage, among others, is the main first-line medication for the treatment of type 2 diabetes, particularly in people who are overweight. From Wikipedia
Findings of reduced dementia risks alongside lower mortality rates are prompting calls for randomized trials to uncover metformin’s protective mechanisms.
